Valuation: Revvity, Inc.

Market Cap 17.26B 87.05B 15.41B 14.32B 13.03B 24.51B 1,635B 24.95B 172B 67.31B 853B 64.78B 63.41B 2,730B P/E 2026 *
65.2x
P/E 2027 * 51.3x
Enterprise Value 19.25B 97.06B 17.18B 15.97B 14.53B 27.33B 1,823B 27.82B 192B 75.05B 951B 72.23B 70.7B 3,044B EV / Sales 2026 *
6.75x
EV / Sales 2027 * 6.22x
Free-Float
99.74%
Yield 2026 *
0.18%
Yield 2027 * 0.18%
1 day+33.98%
1 week+33.98%
Current month+33.98%
1 month+33.98%
3 months+45.26%
6 months+66.57%
Current year+47.59%
1 month 27.47
Extreme 27.47
27.75
Current year 14.91
Extreme 14.91
27.75
1 year 14.91
Extreme 14.91
27.75
3 years 14.51
Extreme 14.51
27.75
5 years 14.51
Extreme 14.51
39.55
10 years 11.96
Extreme 11.957142
39.55
Manager TitleAgeSince
Chief Executive Officer 61 30/12/2019
Director of Finance/CFO 37 06/09/2022
Chief Tech/Sci/R&D Officer - 01/05/2023
Director TitleAgeSince
Chairman 68 30/12/2019
Director/Board Member 74 07/02/2012
Director/Board Member 72 27/07/2016
Change 5-day change 1-year change 3-year change Capi.($)
+33.98%+33.98% - - 17.26B
+3.46%+6.83%+31.94%+44.25% 258B
+3.03%+6.46%+12.32%+10.54% 163B
+1.81%+3.00%-1.78%+56.64% 151B
+2.65%+5.00%-54.83%-10.86% 63.97B
+1.91%+4.58%+20.80%+24.47% 50.78B
+2.00%+6.44%-12.50%-12.61% 50.94B
+0.89%+4.39%+25.71%+58.85% 49.49B
+5.27%+9.90%+8.93%+44.85% 50.68B
+1.73%+3.50%+33.62%+75.82% 43.64B
Average +5.50%+4.66%+7.13%+32.44% 97.88B
Weighted average by Cap. +3.05%+4.04%+11.43%+34.14%

Financials

2026 *2027 *
Net sales 2.85B 14.38B 2.55B 2.37B 2.15B 4.05B 270B 4.12B 28.43B 11.12B 141B 10.7B 10.48B 451B 3.01B 15.17B 2.68B 2.5B 2.27B 4.27B 285B 4.35B 29.97B 11.73B 149B 11.29B 11.05B 476B
Net income 274M 1.38B 244M 227M 207M 389M 25.92B 396M 2.73B 1.07B 13.52B 1.03B 1.01B 43.28B 346M 1.75B 309M 287M 261M 491M 32.79B 500M 3.45B 1.35B 17.11B 1.3B 1.27B 54.74B
Net Debt 1.99B 10.01B 1.77B 1.65B 1.5B 2.82B 188B 2.87B 19.78B 7.74B 98.11B 7.45B 7.29B 314B 1.46B 7.35B 1.3B 1.21B 1.1B 2.07B 138B 2.11B 14.53B 5.69B 72.07B 5.47B 5.36B 231B
Projected Income Statement - Annual - Revvity, Inc.
Logo Revvity, Inc.
Revvity, Inc. specializes in designing, manufacturing, and marketing measurement devices and analytical instruments for the healthcare, environmental, scientific research, industry and food sectors. Net sales break down by family of products as follows: - medical diagnosis equipment (50.1%); - analytical tools and instruments (49.9%): biological molecular research tools, thermal analysis software, chemical and environmental measurement tools, genetic screening instruments, reagents, etc. Net sales break down by source of revenue between sales of products (83.7%) and services (16.3%). Net sales are distributed geographically as follows: America (44%), Europe (28.9%) and Asia (27.1%).
Employees
11,000
Date Price Change Volume
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - Revvity, Inc.
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
154.71USD
Average target price
147.53USD
Spread / Average Target
-4.64%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Revvity, Inc.